Click through to read the NIC Concordat and find more information on NIC Pilot 4

BIVDA is pleased to respond to the MHRA’s public consultation on the revision of European legislation Medical Devices and In Vitro Diagnostics

The British In Vitro Diagnostics Association (BIVDA) welcomes today’s announcement that there will be a review of quality assurance arrangements for NHS pathology services.

The British In Vitro Diagnostics Association (BIVDA) welcomes the report Creating Change: IHW One Year On which was announced alongside The Strategy for UK Life Sciences: One Year On.

The four leading UK human healthcare trade associations welcomed the government’s updated vision for life sciences in the UK.

The British In Vitro Diagnostic Association (BIVDA) welcomes the Chancellor’s continued support for business and science. £600M additional spending on science infrastructure will be welcomed by the UK’s IVD sector employees who work in research and development. It will help Britain maintain its position as a world leader in science research. Additionally, BIVDA welcomes cuts in business taxes and the establishment of a new business bank which will lend to SMEs. Over 90% of the British IVD sector is made up of SMEs and access to finance can still be a major barrier to innovation.

The British Intro Diagnostics Association has submitted to the Health Select Committee’s inquiry into National Institute for Health and Clinical Excellence (NICE)

New objectives for the improvement of health and healthcare have been set out for public consultation, read on for the BIVDA response.

BIVDA has submitted a response to the Liberating the NHS: no decision about me, without me - further consultation on proposals to secure shared decision-making.

BIVDA has submitted a response to the Department of Health's call for evidence on procurement. Read on to find out more.